
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
LAKESHORE BIOP.DL-,000005 H6Z KYG9845F1090 BAW/UFN
© 2024 Xetra Newsboard
Realtime | Geld | Brief | Zeit |
---|---|---|---|
2,060 | 2,200 | 23.02. |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
19.12.24 | LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance | Achieved total revenue of RMB 371.9 million, reflecting a growth of 36.2% YoY
Achieved gross profit of RMB 307.3 million, a growth of 39.1% YoY
Gross margin... ► Artikel lesen | |
13.12.24 | LakeShore Biopharma Co., Ltd: LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China | BEIJING, Dec. 12, 2024 (GLOBE NEWSWIRE) -- LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a leading global biopharmaceutical company focused on the innovation... ► Artikel lesen | |
12.12.24 | LakeShore Biopharma Co., Ltd. - 6-K, Report of foreign issuer | ||
01.11.24 | LakeShore Biopharma Co., Ltd. - 6-K, Report of foreign issuer | ||
29.10.24 | LakeShore Biopharma erfüllt wieder Nasdaq-Anforderungen |